10.05
Precedente Chiudi:
$11.14
Aprire:
$11.06
Volume 24 ore:
291.91K
Relative Volume:
0.77
Capitalizzazione di mercato:
$453.43M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-3.92%
1M Prestazione:
-33.44%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Beta Bionics Inc Stock (BBNX) Company Profile
Nome
Beta Bionics Inc
Settore
Industria
Telefono
949-427-7785
Indirizzo
11 HUGHES, IRVINE
Confronta BBNX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
BBNX
Beta Bionics Inc
|
10.05 | 453.43M | 0 | 0 | 0 | 0.00 |
![]()
ABT
Abbott Laboratories
|
129.89 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
93.58 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
339.59 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
81.80 | 104.24B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
69.20 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-02-24 | Iniziato | BofA Securities | Buy |
2025-02-24 | Iniziato | Lake Street | Buy |
2025-02-24 | Iniziato | Leerink Partners | Outperform |
2025-02-24 | Iniziato | Piper Sandler | Overweight |
2025-02-24 | Iniziato | Stifel | Buy |
2025-02-20 | Iniziato | Ladenburg Thalmann | Neutral |
2025-02-20 | Iniziato | Robert W. Baird | Neutral |
Mostra tutto
Beta Bionics Inc Borsa (BBNX) Ultime notizie
Midday Stock Roundup: Markets Drop around 3% Across the Board - Orange County Business Journal
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 - GlobeNewswire
Beta Bionics, Inc. to Release First Quarter 2025 Financial Results on May 6, 2025 - Nasdaq
Midday Stock Roundup: Evolus, ICU Medical down - Orange County Business Journal
Beta Bionics to Host Investor Event on June 22, 2025 - The Manila Times
CUBE LAUNCHES REGPLATFORM™ INTEL TO TRANSFORM THE MID-MARKET REGULATORY INTELLIGENCE LANDSCAPE IN FINANCIAL SERVICES - The Globe and Mail
Stifel maintains Buy rating on Beta Bionics stock, target at $25 - Investing.com Canada
SCHD ETF News, 4/2/2025 - The Globe and Mail
Beta Bionics, Inc.: Undervalued Growth Opportunity with Strategic Expansion Plans - TipRanks
Beta Bionics shares ‘too cheap’ with estimates going higher, says BofA - TipRanks
Beta Bionics Explodes to $65.1M in Revenue - Orange County Business Journal
Midday Stock Roundup: Rivian Rises - Orange County Business Journal
Newly public Beta Bionics reports sales surge; Dexcom hires CCO - MedTech Dive
Beta Bionics welcomes new board member Gerard Michel By Investing.com - Investing.com Australia
Beta Bionics appoints new board member from Delcath Systems By Investing.com - Investing.com South Africa
Beta Bionics appoints new board member from Delcath Systems - Investing.com India
Beta Bionics welcomes new board member Gerard Michel - Investing.com
Beta Bionics Appoints Gerard Michel as Director - TipRanks
Beta Bionics Announces Board Appointment of Gerard Michel - The Manila Times
Stifel maintains Buy on Beta Bionics stock, $25 price target By Investing.com - Investing.com South Africa
Piper Sandler maintains $26 target on Beta Bionics stock By Investing.com - Investing.com Australia
Piper Sandler maintains $26 target on Beta Bionics stock - Investing.com
Stifel maintains Buy on Beta Bionics stock, $25 price target - Investing.com India
Beta Bionics Reports Strong Growth and Strategic Advances - TipRanks
Beta Bionics Inc (BBNX) Reports Q4 2024 Revenue of $20.4M and Ne - GuruFocus.com
Earnings call transcript: Beta Bionics Q4 2024 sees strong revenue growth - Investing.com Australia
Earnings call transcript: Beta Bionics Q4 2024 sees strong revenue growth By Investing.com - Investing.com South Africa
Beta Bionics stock surges as Q4 revenue more than doubles By Investing.com - Investing.com South Africa
Beta Bionics stock surges as Q4 revenue more than doubles - Investing.com Australia
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 - The Manila Times
Beta Bionics Announces Fourth Quarter and Full Year 2024 - GlobeNewswire
Mining Stock Catches Early Bid Following Bullish Analyst Shift - The Globe and Mail
Head to Head Survey: Arch Therapeutics (OTCMKTS:ARTH) & Beta Bionics (NASDAQ:BBNX) - Defense World
Beta Bionics, Inc.’s Quiet Period Will Expire on March 11th (NASDAQ:BBNX) - Defense World
Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey
Beta Bionics Inc Azioni (BBNX) Dati Finanziari
Non sono disponibili dati finanziari per Beta Bionics Inc (BBNX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):